The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 02, 2026
Snapshot (as of Sep 02, 2026): State Street Health Care Select Sector SPDR ETF (XLV) pays a $2.53 annual dividend ($0.66 quarterly), yielding 1.48% at $171.67/share. Next ex-dividend date 2026-06-22. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 1.48%
Annual Dividend: $2.53 per share
Ex-Dividend Date: 2026-06-22
Dividend Frequency: quarterly
Sector: Financial Services
Years of Dividend History: 28
The State Street Health Care Select Sector SPDR ETF dividend comes from a fund that tracks the Health Care Select Sector Index, giving investors focused exposure to S&P 500 healthcare companies across pharmaceuticals, biotechnology, medical equipment, and health services. XLV currently yields 1.53%, with a trailing annual dividend rate of $2.5326 per share paid quarterly. The next ex-dividend date is June 22, 2026, with the most recent quarterly payment of $0.6562 per share. Growth-and-income investors who want targeted healthcare sector exposure with a 10.2% dividend CAGR over 15 years are the clearest fit here, not those chasing current income.
State Street Health Care Select Sector SPDR ETF pays out dividends as a pass-through of income generated by its underlying holdings, making a traditional payout ratio not applicable (fund/ETF). State Street Health Care Select Sector SPDR ETF dividend safety is anchored to the income produced by its portfolio of S&P 500 healthcare companies spanning pharmaceuticals, medical equipment, and life sciences, sectors with broad and recurring demand. The primary pressure on the dividend is the income variability of those underlying holdings, since any broad decline in distributions from portfolio companies flows directly through to XLV payouts.
State Street Health Care Select Sector SPDR ETF dividend history shows a CAGR of 10.2% per year from 2010 to 2025. Per-share payments grew from $0.5770 to $2.4770 over that window (2026 is a partial year and excluded from this calculation). The largest single-year jump was 61.9% in 2019, though the data window also contains at least one year-over-year decline exceeding 5%, so growth has not been linear.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.5% | $1.99 (2022) | $2.48 (2025) |
| 5-Year | +8.0% | $1.69 (2020) | $2.48 (2025) |
| 10-Year | +9.1% | $1.03 (2015) | $2.48 (2025) |
XLV fits growth-and-income investors who want healthcare sector exposure and are willing to accept a low current yield in exchange for above-average dividend growth. At 1.53%, the yield is classified as low (below 2%), and it sits above the 5-year average of 1.3%, which reflects recent dividend growth rather than a price decline. The 10.2% annual CAGR over 15 years is the defining characteristic of this fund. What an investor gains is a fast-compounding income stream tied to S&P 500 healthcare companies. The trade-off is a starting yield that delivers limited near-term income.
| Payment Date | Amount per Share |
|---|---|
| 2026-06-22 | $0.6562 |
| 2026-03-23 | $0.5947 |
| 2025-12-22 | $0.6570 |
| 2025-09-22 | $0.6250 |
| 2025-06-23 | $0.6300 |
| 2025-03-24 | $0.5650 |
| 2024-12-23 | $0.6220 |
| 2024-09-23 | $0.5770 |
| 2024-06-24 | $0.5730 |
| 2024-03-18 | $0.5230 |
| Year | Total Dividends |
|---|---|
| 2026 | $1.2510 |
| 2025 | $2.4770 |
| 2024 | $2.2950 |
| 2023 | $2.1690 |
| 2022 | $1.9920 |
Project income from XLV with the XLV dividend calculator or track your full portfolio with the dividend tracker.